Highlights:
The global market for animal therapeutics and diagnostics is estimated to increase from $61.0 billion in 2023 to reach $81.2 billion by 2028, at a compound annual growth rate (CAGR) of 5.9% from 2023 through 2028.
The global market for animal therapeutics and diagnostics for pharmaceuticals segment is estimated to increase from $24.6 billion in 2023 to reach $33.3 billion by 2028, at a compound annual growth rate (CAGR) of 6.2% from 2023 through 2028.
The global market for animal therapeutics and diagnostics for feed additives segment is estimated to increase from $21.6 billion in 2023 to reach $27.5 billion by 2028, at a compound annual growth rate (CAGR) of 5.0% from 2023 through 2028.
##img_0##
Report Scope:
The report's scope includes an overview of the global market for animal therapeutics and diagnostics along with an analysis of global market trends; the report uses 2022 as the base year and forecasts 2023 the compound annual growth rate (CAGR) for 2023 to 2028.
The report is designed to be a helpful business tool that will provide a thorough evaluation of the animal therapeutics and diagnostics market. The geographical scope of this study is worldwide, with special interest for markets, trends, and statistics by key geographical regions such as the United States, European countries, and Brazil, Japan, and Australia. The report identifies markets in four segments: vaccines, pharmaceuticals, feed additives, and diagnostics. For the purpose of this study, diagnostics include products that are used at the point of care and are considered rapid tests or kits, in-clinic analyzers, and imaging equipment. Each market segment provides detailed information based on product categories, use of products, forecasts, and competitive analyses.
Report Includes:
- 56 data tables and 143 additional tables
- An overview of the global market for animal therapeutics and diagnostics
- Estimates of the market size and analyses of global market trends with data from 2020-2023, and projections of compound annual growth rates (CAGRs) through 2028
- Assessment of market drivers, opportunities, and restraints, and current trends and technological advances
- Evaluation of the market with a focus of global production of animal healthcare products, vaccines, feed additives, therapeutic and diagnostic drugs
- Analyses of the market shares of the leading suppliers of animal vaccines and therapeutic drugs, the competitive landscape, market positioning, revenue sales and product segments
- Discussion of the role of major providers of vaccines and companion animal products approved for a wide variety of indications, and emerging technologies in the market.
- Analyses of ESG trends and patents granted for animal health products
- Profiles of the leading companies, including Boehringer Ingelheim, DSM Nutritional Products, Merck & Co. Inc., Phibro Animal Health Corp., Virbac S.A., and Zoetis Services LLC
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- What's New in this Report
- Research Methodology
- Information Sources
- Geographic Breakdown
- Segmentation Breakdown
Chapter 2 Summary and Highlights
- Market Outlook
- Market Summary
- Trends Driving the Animal Health Industry
Chapter 3 Market Overview
- Animal Anatomy and Physiology
- Reproductive System
- Avian Anatomy
- Animal Populations in the United States
- Companion Animals
- Food Production Animals
- Meat Consumption
- Animal Populations by Country
Chapter 4 Market Dynamics
- Market Dynamics
- Drivers
- Market Restraints
- Opportunities
- Regulatory Landscape
- Food and Drug Administration (FDA)
- European Medicines Agency (EMA) and Committee for Medicinal Products for Veterinary Use (CVMP)
- Australian Pesticides and Veterinary Medicines Authority (APVMA)
- The Ministry of Agriculture, Livestock and Supply (MAPA) of Brazil
- Antibiotic Use and Resistance in Production Animals
- FDA's Antimicrobial Restrictions
- Levels of Contaminated Meats in the U.S.
- Movement for Lower Amounts of Antibiotics in Livestock Production
- Minimally and Highly Regulated Products
- Animal Drug User Fee Act of 2003
- Animal Drug User Fee Amendments of 2008 (ADUFA II)
- Animal Drug User Fee Amendments of 2013 (ADUFA III)
- Animal Drug User Fee Amendments of 2018 (ADUFA III)
Chapter 5 Global Market for Animal Therapeutics and Diagnostics
Chapter 6 Global Market for Animal Vaccines
- Overview
- Product Introduction
- Active Immunity
- Passive Immunity
- Other Types
- Companion Animals
- Viruses
- Companion Animal Vaccines
- Major Players in the Market for Companion Animal Vaccines
- Vaccine Providers
- Production Animals
- Viruses and Prions
- Production Animal Vaccines
- Major Players in the Market for Production Animal Vaccines
Chapter 7 Global Market for Animal Pharmaceuticals
- Overview
- Animal Pharmaceuticals
- Companion Animal vs. Production Animal Markets
- Animal Pharmaceuticals Market by Region
- Allergy and Respiratory Drugs
- Companion Animals: Allergy and Inflammatory Diseases
- Major Players in the Market for Animal Allergy and Respiratory Drugs
- Animal Allergy and Respiratory Drugs
- Anti-infectives
- Companion Animals-Bacterial Infections
- Production Animals-Bacterial Infections
- Major Players in the Market for Animal Drugs
- Animal Anti-infectives
- Anti-inflammatories and Analgesics
- Major Players in the Market for Animal Anti-Inflammatory and Analgesic Drugs
- Animal Anti-Inflammatory and Analgesic Drugs
- Metabolic and Endocrine Disorder Drugs
- Metabolic Diseases and Endocrine Disorders
- Major Players in the Market for Animal Metabolic and Endocrines
- Animal Metabolic Drugs
- Parasiticides
- Companion Animals-Parasitic Diseases
- Production Animals-Parasitic Disease Example
- Major Players in the Market for Animal Parasiticides
- Animal Parasiticides
- Psychotropic Medications
- Major Players in the Market for Animal Psychotropic Medications
- Natural Remedies
- Animal Psychotropic Medications
- Other Pharmaceuticals
- Companion Animals-Other Diseases
- Major Players in Market for Other Animal Pharmaceuticals
- Dental
- Other Animal Pharmaceuticals
Chapter 8 Global Market for Animal Feed Additives
- Overview
- Animal Feed Additives
- Companion Animal vs. Production Animal Market Size
- Market for Animal Feed Additives by Region
- Major Players in the Market for Animal Feed Additives
- Amino Acids
- Major Players in the Market for Amino Acids for Animals
- Amino Acids for Animals
- Medicinal Additives
- Major Players in the Market for Medicinal Additives for Animals
- Medicinal Feed Additives
- Nutritional Supplements
- Major Players in the Market for Animal Nutritional Supplements
- Nutritional Supplement Market Analysis
- Vitamins and Minerals
- Major Players in the Market for Vitamins and Minerals for Animals
- Vitamins and Minerals for Animals
Chapter 9 Global Market for Animal Diagnostics
- Overview
- Animal Diagnostics
- Companion Animal vs. Production Animal Markets
- Market for Animal Diagnostics by Region
- Diagnostic Test Descriptions
- Centralized and Decentralized Laboratory Tests
- Diagnostic Imaging
- Major Players in the Market for Animal Diagnostics
- Market for Animal Diagnostics by Product
- Diagnostic Rapid Testing
- Diagnostic Analyzers and Consumables
- Diagnostic Imaging Equipment
Chapter 10 Global Market for Animal Therapeutics and Diagnostics by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 11 ESG Developments
- Introduction to ESG
- Importance of ESG in the Animal Therapeutics and Diagnostics Industry
- Key ESG Issues in the Animal Therapeutics and Diagnostics Industry
- ESG Ratings and Metrics: Understanding the Data
- ESG Practices in the Animal Therapeutics and Diagnostics Industry
- Future Trends
- BCC Research Viewpoint
Chapter 12 M&A and Funding Analysis
- M&A Analysis
- Funding in the Animal Healthcare Industry
Chapter 13 Competitive Intelligence
- Top Market Players 2022
- Key Strategies Adopted by Companies
- Mergers & Acquisitions
- New Product Launches
- Partnerships
- Approvals
- Others
Chapter 14 Company Profiles
- ARKO LABORATORIES
- AVIMEX
- BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- CEVA SANTE ANIMALE (CEVA)
- DECHRA PHARMACEUTICALS PLC
- DSM NUTRITIONAL PRODUCTS
- ELANCO ANIMAL HEALTH INC.
- MERCK & CO. INC.
- PHIBRO ANIMAL HEALTH CORP.
- VIRBAC S.A.
- ZOETIS INC.